NLRP3 is a potential therapeutic target in a mouse model of chronic mild stress‐induced depression, and it may be a central mediator in the treatment of lipopolysaccharide (LPS)‐induced depression (Iwata et al., 2013; Zhang et al., 2014, 2015). The gene discussed is NLRP3; the disease is major depressive disorder.